References
- Alizadeh AA, Eisen MB, Davis RE, . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
- Hans CP, Weisenburger DD, Greiner TC, . Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275–282.
- Porrata LF, Ristow K, Habermann TM, . Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma. Leuk Lymphoma 2012;53:2159–2165.
- Monti S, Savage KJ, Kutok JL, . Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105: 1851–1861.
- Wilcox RA, Ristow K, Habermann TM, . The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 2011;25: 1502–1509.
- Kim DH, Baek JH, Chae YS, . Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia 2007;21:2227–2230.
- Lin Y, Gustafson MP, Bulur PA, . Immunosuppressive CD14 + HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. Blood 2011;117:872–881.
- Mantovani A, Sica A, Sozzani S, . The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677–686.